Maze Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $20,000 | $0 | $0 | $0 |
Gross Profit | 19,556 | -499 | -649 | |
EBITDA | -22,898 | -34,069 | -29,516 | -33,030 |
EBIT | -23,342 | -34,568 | -30,087 | -33,679 |
Net Income | -24,208 | -34,568 | -30,087 | -33,679 |
Net Change In Cash | 20,000 | 0 | 0 | 0 |
Free Cash Flow | -39,206 | -27,764 | -24,710 | -30,445 |
Cash | 198,766 | 189,247 | 316,773 | 264,541 |
Basic Shares | 53,897 | 42,976 | 45,779 | 43,850 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $167,500 | $0 | $0 |
Gross Profit | -2,403 | 167,500 | -4,089 | -3,820 |
EBITDA | -128,717 | 56,700 | -96,326 | -111,120 |
EBIT | -131,120 | 53,403 | -100,415 | -114,940 |
Net Income | -131,120 | 52,231 | -100,415 | -114,940 |
Net Change In Cash | 0 | 167,500 | 0 | 0 |
Free Cash Flow | -112,734 | 74,807 | -87,268 | -101,169 |
Cash | 189,247 | 196,812 | 29,158 | 99,919 |
Basic Shares | 42,976 | 43,796 | 43,776 | 43,776 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.44 |
2025-12-31 | -$0.65 |
2025-09-30 | -$0.66 |
2025-06-30 | -$0.77 |